Supplements · Metabolic & Cardiometabolic
creatine prevents cancer
In plain terms: Does creatine fight cancer?
Part of: 🧪 creatine
The evidence leans the other way. In animal studies creatine has actually promoted cancer spread, and blocking it slowed colon cancer — the opposite of 'anti-cancer.' Its role is complex and unproven in humans, and there's no basis to take it to prevent cancer.
📅 Last reviewed: 2026-07-14 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: Animal studies (Animal)
How the studies fall
What the evidence shows
Claimed as 'anti-cancer properties' — the preclinical reality is the opposite-leaning and mixed: mouse studies show creatine can promote cancer metastasis (Smad2/3), and blocking the creatine transporter suppresses colon-cancer growth. Reviews describe dual, context-dependent roles. No human evidence of cancer prevention exists — graded leans-against.
The evidence (12)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Demir M et al 2026 · study_type: in-vitro | in-vitro | contradicts | moderate | Mitochondrial creatine kinase (MtCK) is overexpressed in many cancer cells to meet energy demand and linked to poor prognosis; authors develop small-molecule inhibitors of MtCK as a breast-cancer therapeutic strategy. |
| Bao W et al 2026 · study_type: animal | animal | contradicts | moderate | SLC6A8 (creatine transporter) is upregulated in hepatocellular carcinoma and associated with poor prognosis; genetic/pharmacological SLC6A8 blockade (RGX-202) suppressed HCC tumor growth in vitro and in xenograft mice, enhancing ferroptosis |
| Wang JD et al 2026 · study_type: mechanism | mechanism | contradicts | moderate | In NPM1-mutant AML, FTO-driven creatine anabolism promotes macrophage M2 polarization (pro-tumor immunosuppressive phenotype), described as playing an 'oncogenic role.' |
| Rao L et al 2025 · study_type: observational | observational | tested-null | moderate | Retrospective cohort (n=1,651) found platelet-derived creatine-kinase isoenzymes (CKB, mitochondrial CK) drive paradoxical serum CK-MB elevations in cancer patients, with CKB expression enriched specifically in metastatic tumor cells. |
| Zhang 2022 · Trends Cell Biol | observational | mixed | low | Review: creatine has dual, context-dependent roles in cancer — both anti-tumor and pro-tumor mechanisms are reported. |
| Kang E et al 2026 · study_type: animal | animal | supports | moderate | Creatine transporter (CrT) upregulation and creatine supplementation enhanced mouse and human dendritic-cell activation, boosting antigen-specific CD8 T-cell responses, and creatine supplementation suppressed tumor growth in a syngeneic mel |
| Zhang 2021 · Cell Metab | animal | contradicts | moderate | Orthotopic mouse models: creatine PROMOTED cancer metastasis via Smad2/3 — an adverse, not protective, effect. |
| Shin J et al 2026 · study_type: animal | animal | mixed | moderate | Systematic review of 5 preclinical studies: creatine supplementation combined with PD-1 blockade improved T-cell/macrophage-driven antitumor immunity in some tumor models, but conflicting reports show creatine-associated metastasis in selec |
| Wang K et al 2026 · study_type: mechanism | mechanism | contradicts | moderate | Review notes SLC6A8 (creatine transporter) is aberrantly overexpressed across many cancers, and that INHIBITING it (RGX-202/ompenaclid) shows broad antitumor activity in preclinical colorectal/hepatocellular models. |
| Longobardi I, Solis MY, Roschel H, Gualano B 2025 · Frontiers in Nutrition | observational | mixed | low | Short narrative review, section 2. WRONG-OUTCOME FIX: the previous extract quoted this review's carcinogenicity verdict ('does not support a link between creatine supplementation and cancer risk'), which answers whether creatine CAUSES cancer — not this claim, whose predicate is 'prevents'. On prevention/anti-tumour effect the review is genuinely two-sided and refuses to resolve it. FOR: 'creatine and cyclocreatine (its analog) have been shown to delay tumor growth in vitro and animal models and acts as an anticancer agent, working synergistically with chemotherapeutic drugs'; 'a considerable number of studies have shown that creatine and cyclocreatine can inhibit tumor growth'; 'creatine supplementation has been demonstrated to enhance the activity of CD8 T cells'; and one observational human signal, 'data from the National Health and Nutrition Examination Survey (NHANES), which indicates that higher dietary creatine intake is associated with a lower risk of cancer or malignancy' — dietary intake, not supplementation. AGAINST: 'emerging experimental evidence has linked creatine to cancer progression and metastasis, particularly through the phosphocreatine energy shuttle mediated by creatine kinase in cancer cells'; Zhang et al. 'observed that creatine-treated mice presented with colorectal and breast cancer metastases through Smad2/3 activation'; human liver metastases over-express creatine kinase and the SLC6A8 transporter. The authors' own bottom line is non-committal: 'the complexity of the diversity of cancer types, tumors, and experimental models, along with the inherent differences between species, limits our ability to predict creatine' effects in oncological treatments. Further studies are warranted.' Table 1 offers no prevention verdict at all — its cancer row grades only the SAFETY question ('No human studies support an increased carcinogenicity'). Ceiling-relevant: every prevention-direction finding here is in vitro or animal except the NHANES association. Manufacturer COI: AlzChem paid the APCs; senior author sits on AlzChem's Scientific Advisory Board. |
| Kurth 2021 · Sci Adv | animal | contradicts | moderate | Animal study: inhibiting the SLC6A8 creatine transporter suppressed colon-cancer progression, implying creatine availability supports tumor growth. |
| Kazak 2020 · Nat Rev Endocrinol | observational | mixed | low | Review: creatine metabolism has complex roles in immunity and cancer biology; not a clean anti-cancer agent. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.